Plain-English translation of NCT05312892 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
Researchers at Vanderbilt University are studying how , a medication that blocks certain nerve signals in the body, affects blood sugar production in people who have obesity and high blood pressure. The study will compare to a common blood pressure medication () and a placebo (inactive pill) to see which approach works best. This is an early-stage study with only 12 participants.
Scientists know that obesity and high blood pressure are linked to overactivity in the nervous system, which may affect how the body handles blood sugar. This trial aims to test whether blocking these nerve signals could help improve metabolic health in people with both conditions.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic three separate times, spaced at least one week apart. Before each visit, you will take either a placebo, , or for two weeks—you won't know which one. During each clinic visit, researchers will measure your blood sugar production and other metabolic markers. The order of treatments will be randomly assigned by computer to make the study fair and unbiased.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States